Filing Details

Accession Number:
0001415889-24-019471
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-10 17:33:52
Reporting Period:
2024-07-08
Accepted Time:
2024-07-10 17:33:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1679363 Morphic Holding Inc. MORF Pharmaceutical Preparations (2834) 473878772
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1779978 P. Praveen Tipirneni C/O Morphic Holding, Inc.
35 Gatehouse Drive, A2
Waltham MA 02451
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-08 21,582 $4.32 64,042 No 4 M Direct
Common Stock Disposition 2024-07-08 21,582 $55.79 42,460 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2024-07-08 21,582 $0.00 21,582 $4.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
339,561 2028-12-14 No 4 M Direct
Footnotes
  1. Includes 447 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 29, 2024.
  2. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.79 to $55.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The option is fully vested.